Search results
After Pegasus Was Blacklisted, Its CEO Swore Off Spyware. Now He’s the King of Israeli AI.
The Intercept· 2 days agoShalev Hulio, once dubbed “Israel’s cyber bad boy,” has been working hard to remake himself. Things...
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today - ResMed...
Benzinga· 2 days agoHow much a stock's price changes over time is important for most investors, since price performance...
ANNOUNCING: Our 2024 Best Places to Work in Greater Louisville - Louisville Business First
The Business Journals· 3 days agoDoes your company have what it takes to be a best place to work according to your employees? These...
TScan Therapeutics (NASDAQ:TCRX) Earns Buy Rating from Analysts at BTIG Research
ETF DAILY NEWS· 6 days agoBTIG Research assumed coverage on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports ...
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today
Zacks· 2 days agoHow much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors ...
Genetic test may tell who will benefit most from injected weight-loss medications
UPI· 4 days agoResearch shows that a new test that assigns a genetic risk score to patients may be able to spot who...
Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
Centers for Disease Control and Prevention· 1 day agoA 3-year-old boy was admitted to the All India Institute of Medical Sciences, New Delhi, India, with headache for 3 weeks and 2 episodes of seizures. Fundoscopic examination revealed bilateral ...
Nyxoah (NASDAQ:NYXH) PT Lowered to $17.00 at Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoNyxoah (NASDAQ:NYXH – Free Report) had its target price decreased by Cantor Fitzgerald from $18.00 to $17.00 in a research note published on Wednesday morning, Benzinga reports ...
Pliant Therapeutics (NASDAQ:PLRX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 6 days agoHC Wainwright reissued their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a research note released on Wednesday, Benzinga reports. HC Wainwright ...
Cantor Fitzgerald Comments on Nyxoah S.A.’s FY2024 Earnings (NASDAQ:NYXH)
ETF DAILY NEWS· 6 days agoNyxoah S.A. (NASDAQ:NYXH – Free Report) – Cantor Fitzgerald upped their FY2024 earnings estimates for Nyxoah in a research note issued to investors on Wednesday, May 15th.